These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36394179)
1. Targeting Theranostics of Atherosclerosis by Dual-Responsive Nanoplatform via Photoacoustic Imaging and Three-In-One Integrated Lipid Management. Ma B; Xiao Y; Lv Q; Li G; Wang Y; Fu G Adv Mater; 2023 Feb; 35(5):e2206129. PubMed ID: 36394179 [TBL] [Abstract][Full Text] [Related]
2. Targeting Nanoplatform for Atherosclerosis Inhibition and Degradation via a Dual-Track Reverse Cholesterol Transport Strategy. Chen Z; Zhu Q; Li D; Lv Q; Fu G; Ma B; Zhang W Small; 2024 Feb; 20(7):e2306457. PubMed ID: 37803917 [TBL] [Abstract][Full Text] [Related]
3. Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy. Xu H; She P; Zhao Z; Ma B; Li G; Wang Y Adv Mater; 2023 May; 35(21):e2300439. PubMed ID: 36828777 [TBL] [Abstract][Full Text] [Related]
4. Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics. Wang Y; Chen Z; Zhu Q; Chen Z; Fu G; Ma B; Zhang W Bioact Mater; 2024 Jul; 37():94-105. PubMed ID: 38523705 [TBL] [Abstract][Full Text] [Related]
5. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages. Jin P; Bian Y; Wang K; Cong G; Yan R; Sha Y; Ma X; Zhou J; Yuan Z; Jia S Life Sci; 2018 Dec; 214():41-50. PubMed ID: 30393020 [TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics. Ni H; Zhou H; Liang X; Ge Y; Chen H; Liu J; Wang B; Chen H; Zhang Y; Luo S; Chen Y; Lu X; Yin C; Fan Q ACS Nano; 2024 Aug; 18(34):23599-23614. PubMed ID: 39141682 [TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques. He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284 [TBL] [Abstract][Full Text] [Related]
8. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells. Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381 [TBL] [Abstract][Full Text] [Related]
9. ROS Responsive Nanoplatform with Two-Photon AIE Imaging for Atherosclerosis Diagnosis and "Two-Pronged" Therapy. Ma B; Xu H; Zhuang W; Wang Y; Li G; Wang Y Small; 2020 Nov; 16(45):e2003253. PubMed ID: 33078569 [TBL] [Abstract][Full Text] [Related]
10. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics. Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950 [TBL] [Abstract][Full Text] [Related]
11. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. Gabunia K; Ellison S; Kelemen S; Kako F; Cornwell WD; Rogers TJ; Datta PK; Ouimet M; Moore KJ; Autieri MV Am J Pathol; 2016 May; 186(5):1361-74. PubMed ID: 26952642 [TBL] [Abstract][Full Text] [Related]
12. An Ultrasound-Responsive Theranostic Cyclodextrin-Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis. Mehta S; Bongcaron V; Nguyen TK; Jirwanka Y; Maluenda A; Walsh APG; Palasubramaniam J; Hulett MD; Srivastava R; Bobik A; Wang X; Peter K Small; 2022 Aug; 18(31):e2200967. PubMed ID: 35710979 [TBL] [Abstract][Full Text] [Related]
13. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice. Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450 [TBL] [Abstract][Full Text] [Related]
14. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841 [TBL] [Abstract][Full Text] [Related]
15. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet. Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759 [TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway. Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667 [TBL] [Abstract][Full Text] [Related]
17. Characterization of lipid-rich aortic plaques by intravascular photoacoustic tomography: ex vivo and in vivo validation in a rabbit atherosclerosis model with histologic correlation. Zhang J; Yang S; Ji X; Zhou Q; Xing D J Am Coll Cardiol; 2014 Jul; 64(4):385-90. PubMed ID: 25060374 [TBL] [Abstract][Full Text] [Related]
18. A Novel Candidate for Prevention and Treatment of Atherosclerosis: Urolithin B Decreases Lipid Plaque Deposition in apoE Zhao W; Wang L; Haller V; Ritsch A Mol Nutr Food Res; 2019 May; 63(10):e1800887. PubMed ID: 30762936 [TBL] [Abstract][Full Text] [Related]
19. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner. Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950 [TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis. Wang Y; Gao H; Huang X; Chen Z; Kang P; Zhou Y; Qin D; Zhang W; Liu J Carbohydr Polym; 2022 Sep; 292():119632. PubMed ID: 35725197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]